Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Amanda Gilmore and Rachel Tomko.
Connection Strength

0.703
  1. Depressive symptoms and cannabis use in a placebo-controlled trial of N-Acetylcysteine for adult cannabis use disorder. Psychopharmacology (Berl). 2020 Feb; 237(2):479-490.
    View in: PubMed
    Score: 0.176
  2. Corrigendum to The role of depressive symptoms in treatment of adolescent cannabis use disorder with N-Acetylcysteine Addictive Behaviors 85 (2018) 26-30. Addict Behav. 2019 Feb; 89:263.
    View in: PubMed
    Score: 0.163
  3. N-acetylcysteine: A potential treatment for substance use disorders. Curr Psychiatr. 2018 06; 17(6):30-36, 41-42, 55.
    View in: PubMed
    Score: 0.159
  4. The role of depressive symptoms in treatment of adolescent cannabis use disorder with N-Acetylcysteine. Addict Behav. 2018 10; 85:26-30.
    View in: PubMed
    Score: 0.159
  5. Impact of disaster exposure severity: Cascading effects across parental distress, adolescent PTSD symptoms, as well as parent-child conflict and communication. Soc Sci Med. 2020 11; 264:113293.
    View in: PubMed
    Score: 0.046
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.